Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Cancer Epidemiology|August 26, 2020
Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective studyChristine M White, Salih Bakhiet, Mark Bates, et al.Journal of Ovarian Research|January 21, 2012
Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samplesMichael F Gallagher, Cynthia Cbb Heffron, Alexandros Laios, et al.International Journal of Molecular Sciences|August 7, 2021
LncRNA MORT (ZNF667-AS1) in Cancer-Is There a Possible Role in Gynecological Malignancies?Riccardo Di Fiore, Sherif Suleiman, Rosa Drago-Ferrante, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 11, 2026
Memorable Medicine: How the BEAT Campaign could Impact the Future of Ovarian CancerFaye Lewis, Lea Schäfer, Una Kennedy, et al.International Journal of Molecular Sciences|April 30, 2021
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief OverviewRiccardo Di Fiore, Sherif Suleiman, Francesca Pentimalli, et al.Gynecologic Oncology|November 20, 2020
HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node statusSharon A O'Toole, Yanmei Huang, Lucy Norris, et al.Breast Cancer Research and Treatment|May 8, 2020
Circulating tumour cell enumeration does not correlate with Miller-Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapySharon A O'Toole, Cathy Spillane, Yanmei Huang, et al.Molecular Cancer|April 1, 2021
Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?Mark P Ward, Laura E Kane, Lucy A Norris, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2008
Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patientsRichard J Flavin, Paul C Smyth, Stephen P Finn, et al.Frontiers in Cell and Developmental Biology|December 25, 2023
Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapyTanya E Kelly, Cathy L Spillane, Mark P Ward, et al.Pageof 3